We are thrilled to announce that our upcoming October workshop is now fully booked! The overwhelming response from the community has been incredible, and we're grateful for your enthusiasm and interest in our workshop.

For those who were unable to secure a spot in the current event, we will be announcing more workshops for 2024 towards the end of the year!


Dates: October 16-18, 2023

Location: IMBA, Dr. Bohr-Gasse 3, 1030 Vienna, Austria

Hosted By: IMBA Stem Cell Core Facility


This hands-on workshop provides skills of handling and genetically modifying human embryonic stem cells as well as generating induced pluripotent stem cells (iPSC).

To provide a comfortable learning experience and allow for personalized interactions between the instructors and attendees, the numbers are limited to a maximum of four (4) students.



·         Reprogramming of human dermal fibroblasts to iPSCs

·         Feeding, passaging and assessment of human ES cultures

·         Freezing and thawing of human ES cells

·         Gene editing of human ES cells using CRISPR/Cas9 technology

This course is highly practical and will be based in a Class II tissue culture facility. All relevant safety equipment, clothing and training will be provided.



To register, please send an Email to sccf.GRP(at)imba.oeaw.ac.at including the following information:

Full name (including title – Mr, Ms, Mx, Dr, Prof)
Current job/position
Company/organization & address
Statement of motivation: describe in max 300 words your reason for attending, i.e., specific field of interest (i.e. gene editing, organoids), past experience with stem cells, future stem cell applications.

Registration fee:

€ 1140,- Academics

€ 1520,- Non-Academics

Fees include course materials, tuition and 3x lunches. The price does not include accommodation.



Participants who attend the full course will receive a Certificate of Attendance.



Dr Jennifer Volz 

Jennifer joined the Stem Cell Facility in March 2016. By training a molecular biologist, she is responsible for the mouse gene editing platform, human stem cell reprogramming, biobanking (iPSC Biobank) and QC.

Dr Sofia Aligianni 

Sofia joined the Stem Cell Facility in April 2018 after working for 2 years in a CRISPR gene-editing company. She has background in molecular and stem cell biology and leads the human stem cell gene editing platform and reagents’ QC.